28.01.2014 Views

m-Cresol - ipcs inchem

m-Cresol - ipcs inchem

m-Cresol - ipcs inchem

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

OECD SIDS<br />

m- / p-CRESOL<br />

Table 5:<br />

m-<strong>Cresol</strong>: Repeated Dose Toxicity Rat/Mouse<br />

Study-Description NOAEL Effects Reference<br />

Rat<br />

5 rats/sex/dose, 28 d, feeding<br />

0, 300, 1000, 3000, 10,000,<br />

30,000 ppm<br />

(m: 0, 25, 85, 252, 870, 2470<br />

mg/kg bw/day;<br />

f: 0, 25, 82,252, 862, 2310<br />

mg/kg bw/day),<br />

30 rats/sex/dose, 13 w gavage<br />

0, 50, 150, 450 mg/kg bw/day in<br />

corn oil<br />

10 rats/sex/dose, 13 w gavage<br />

20 rats/sex as control<br />

0, 50, 150, 450 mg/kg bw/day<br />

in corn oil<br />

neurotoxicity study<br />

available as summary only<br />

Mouse<br />

5 mice/sex/dose, 28 d feeding<br />

0, 300, 1000, 3000, 10,000,<br />

30,000 ppm<br />

(m: 0, 53, 193, 521,1730, 4710<br />

mg/kg bw;<br />

f: 0, 66, 210, 651, 2080, 4940<br />

mg/kg bw)<br />

3000 ppm<br />

(252<br />

mg/kg<br />

bw/day)<br />

Males: 50<br />

mg/kg<br />

bw/day<br />

Females:<br />

150<br />

mg/kg<br />

bw/day<br />

No mortality, no clinical signs of toxicity<br />

30,000 ppm, m, f: decreased body weight gain and<br />

final body weight, decreased food consumption,<br />

minimal to mild uterine atrophy in 4/5 females; no<br />

histopathological changes in other organs<br />

≥ 10,000 ppm: increased rel liver weights<br />

450 mg: 1 male died (gavage error), lethargy, tremor,<br />

hunched posture, dyspnoe, reduced body weight gain,<br />

decreased food consumption (m); no histopathological<br />

changes<br />

150 mg: reduced bw gain (m)<br />

* 450 mg: reduced food consumption (m,f) convulsions,<br />

death of 1 female, urination ↑ (f)<br />

1000 ppm<br />

(m: 193<br />

mg/kg<br />

bw/day),<br />

< 300<br />

ppm (f, 66<br />

mg/kg<br />

bw/day)<br />

≥ 50 mg: clinical signs as salivation, urine wet<br />

abdomen, hypoactivity, rapid and labored respiration,<br />

myoclonus, hyperreactivity<br />

Mortality: 1/5 control male; 30,000 ppm: 2/5 f, 2/5 m;<br />

10,000 ppm: 1/5 f<br />

30,000 ppm, m,f: reduced body weight gain, and final<br />

body weight, decreased food consumption, thin<br />

appearance, lethargy, tremor, hypothermia (f only), in<br />

females atrophy of mammary gland, ovaries, uterus;<br />

no histopathological changes in liver and kidneys<br />

NTP 1991<br />

Microbiolo<br />

gical<br />

Associates<br />

Inc 1988a<br />

TRL 1986<br />

NTP 1991<br />

≥ 10,000 ppm, m,f: hunched posture, rough hair coat,<br />

laboured breathing(only f)<br />

≥ 3000 ppm: increased rel liver weight (m)<br />

≥ 300 ppm: increased rel liver weight (f)<br />

* due to limitations in the study documentation, NOAELs were not derived<br />

UNEP PUBLICATIONS 21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!